Mouhammed Amir Habra

Mouhammed Amir Habra is a Professor at The University of Texas MD Anderson Cancer Center, where he specializes in endocrine oncology. His research focuses on adrenocortical carcinoma, adrenal disease, and the molecular pathology of endocrine cancers, with particular emphasis on prognostic biomarkers, surgical outcomes, and adjuvant radiation therapy. His recent work includes a computed tomography-based survival prediction score for adrenocortical carcinoma, the association of this malignancy with Birt–Hogg–Dubé syndrome, and investigations into β-catenin’s role as a molecular adapter in disordered cBAF interactions. He has published extensively in journals such as Endocrinology and Metabolism Clinics of North America, Endocrine Related Cancer, and Molecular Cell, and is recognized as a senior leader in translational cancer research.